Regulation of hematopoietic stem cells differentiation, self-renewal, and quiescence through the mTOR signaling pathway
暂无分享,去创建一个
Siyuan Qian | Ze Xiang | B. Ling | Shihai Xuan | Jian Wu | Yunyang Xu
[1] Yilun Huang,et al. The Challenge of Applications of Probiotics in Gastrointestinal Diseases , 2023, Advanced Gut & Microbiome Research.
[2] Ming Li,et al. Gut Microbiota Promotes Immune Tolerance by Regulating RORγt+ Treg Cells in Food Allergy , 2022, Advanced Gut & Microbiome Research.
[3] Xu‐yong Wei,et al. Advances in multi-omics research on viral hepatitis , 2022, Frontiers in Microbiology.
[4] Wenyu Li,et al. An Insight into the Clinical Application of Gut Microbiota during Anticancer Therapy , 2022, Advanced Gut & Microbiome Research.
[5] A. Yáñez,et al. Direct TLR2 signaling through mTOR and TBK1 induces C/EBPβ and IRF7-dependent macrophage differentiation in hematopoietic stem and progenitor cells. , 2022, Stem cells.
[6] Y. Cao,et al. Myh9 Plays an Essential Role in the Survival and Maintenance of Hematopoietic Stem/Progenitor Cells , 2022, Cells.
[7] Pathomthat Srisuk,et al. Prevention of acute graft-vs.-host disease by targeting glycolysis and mTOR pathways in activated T cells , 2022, Experimental and therapeutic medicine.
[8] E. Papoutsakis,et al. miR-486-5p and miR-22-3p Enable Megakaryocytic Differentiation of Hematopoietic Stem and Progenitor Cells without Thrombopoietin , 2022, International journal of molecular sciences.
[9] Qi Jiang,et al. Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection , 2021, Frontiers in Immunology.
[10] Shui-Fang Jin,et al. Intestinal microecology: A crucial strategy for targeted therapy of liver diseases. , 2021, Hepatobiliary & pancreatic diseases international : HBPD INT.
[11] E. Szegezdi,et al. Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities. , 2021, Blood reviews.
[12] Guanbin Song,et al. Nuclear DEK preserves hematopoietic stem cells potential via NCoR1/HDAC3-Akt1/2-mTOR axis , 2021, The Journal of experimental medicine.
[13] E. Carvalho,et al. mTOR Signaling as a Regulator of Hematopoietic Stem Cell Fate , 2021, Stem Cell Reviews and Reports.
[14] Y. Dou,et al. ER associated degradation preserves hematopoietic stem cell quiescence and self-renewal by restricting mTOR activity. , 2020, Blood.
[15] B. Comrie,et al. Stems , 2020, A Grammar of Akabea.
[16] Lanjuan Li,et al. Altered faecal microbiota on the expression of Th cells responses in the exacerbation of patients with hepatitis E infection , 2020, Journal of viral hepatitis.
[17] R. Schneider,et al. Hematopoietic Stem and Progenitor Cells Exhibit Stage-Specific Translational Programs via mTOR- and CDK1-Dependent Mechanisms. , 2020, Cell stem cell.
[18] D. Papatsenko,et al. Restraining Lysosomal Activity Preserves Hematopoietic Stem Cell Quiescence and Potency. , 2020, Cell stem cell.
[19] G. Schabbauer,et al. Macrophage Rewiring by Nutrient Associated PI3K Dependent Pathways , 2019, Front. Immunol..
[20] Yusuke Takahashi,et al. Hypoxia Up-regulates HIF Expression While Suppressing Cell Growth and NOTCH Activity in Leukaemia Cells , 2019, AntiCancer Research.
[21] E. Pietras,et al. PI3 kinase alpha and delta promote hematopoietic stem cell activation. , 2019, JCI insight.
[22] H. Hua,et al. Targeting mTOR for cancer therapy , 2019, Journal of Hematology & Oncology.
[23] D. Marks,et al. Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic niche , 2019, EMBO reports.
[24] T. Suda,et al. PRMT5 Modulates Splicing for Genome Integrity and Preserves Proteostasis of Hematopoietic Stem Cells. , 2019, Cell reports.
[25] D. Shore,et al. Sfp1 regulates transcriptional networks driving cell growth and division through multiple promoter-binding modes , 2019, Genes & development.
[26] Z. Ju,et al. Rheb1 loss leads to increased hematopoietic stem cell proliferation and myeloid-biased differentiation in vivo , 2018, Haematologica.
[27] Naizhou Guo,et al. The Protective Effects and the Involved Mechanisms of Tanshinone IIA on Sepsis-Induced Brain Damage in Mice , 2018, Inflammation.
[28] N. Schmitz,et al. Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas. , 2018, Blood.
[29] P. L. Bergsagel,et al. Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement , 2018, Bone Marrow Transplantation.
[30] J. McCubrey,et al. Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update , 2018, International Journal of Molecular Sciences.
[31] A. Bigas,et al. Blood Development: Hematopoietic Stem Cell Dependence and Independence. , 2018, Cell stem cell.
[32] P. Pedrazzoli,et al. Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies , 2018, Science Translational Medicine.
[33] P. Lauzurica,et al. Anti-CD69 therapy induces rapid mobilization and high proliferation of HSPCs through S1P and mTOR , 2018, Leukemia.
[34] P. Kurre,et al. Extracellular vesicles in the hematopoietic microenvironment , 2018, Haematologica.
[35] Lei Han,et al. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF‐β/PI3K‐AKT‐mTOR signaling pathway , 2018, Journal of cellular biochemistry.
[36] D. Lim,et al. Mammalian sterile 20 kinase 1 and 2 are important regulators of hematopoietic stem cells in stress condition , 2018, Scientific Reports.
[37] Gopal Jayaraj,et al. Pathways of cellular proteostasis in aging and disease , 2018, The Journal of cell biology.
[38] S. Bhatia,et al. How I monitor long-term and late effects after blood or marrow transplantation. , 2017, Blood.
[39] A. Ganser,et al. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel. , 2017, Blood.
[40] E. Holler,et al. Pathophysiology of GvHD and Other HSCT-Related Major Complications , 2017, Front. Immunol..
[41] David M. Sabatini,et al. mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.
[42] T. Cheng,et al. Rictor has a pivotal role in maintaining quiescence as well as stemness of leukemia stem cells in MLL-driven leukemia , 2017, Leukemia.
[43] B. Groner,et al. O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies , 2017, Leukemia.
[44] Anurag K Singh,et al. Allogeneic Stem Cell Transplantation: A Historical and Scientific Overview. , 2016, Cancer research.
[45] Kateri Moore,et al. Hematopoietic Stem Cells Count and Remember Self-Renewal Divisions , 2016, Cell.
[46] J. Hamerman,et al. Cutting Edge: Direct Sensing of TLR7 Ligands and Type I IFN by the Common Myeloid Progenitor Promotes mTOR/PI3K-Dependent Emergency Myelopoiesis , 2016, The Journal of Immunology.
[47] S. Giorgetti-Peraldi,et al. Disruption of Glut1 in Hematopoietic Stem Cells Prevents Myelopoiesis and Enhanced Glucose Flux in Atheromatous Plaques of ApoE(-/-) Mice. , 2016, Circulation research.
[48] W. Linehan,et al. Loss of Folliculin Disrupts Hematopoietic Stem Cell Quiescence and Homeostasis Resulting in Bone Marrow Failure , 2016, Stem cells.
[49] Xi C. He,et al. The Dlk1-Gtl2 Locus Preserves LT-HSC Function by Inhibiting the PI3K-mTOR Pathway to Restrict Mitochondrial Metabolism. , 2016, Cell stem cell.
[50] J. Taube,et al. Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer. , 2016, Cancer research.
[51] A. Syme,et al. Phosphorylation of eIF2α Is a Translational Control Mechanism Regulating Muscle Stem Cell Quiescence and Self-Renewal. , 2016, Cell stem cell.
[52] D. Link,et al. The hematopoietic stem cell niche in homeostasis and disease. , 2015, Blood.
[53] Yuan Wang,et al. The extended spectrum β-lactamases (ESBL) and virulence genes of intestinal enteroaggregative Escherichia coli (EAEC) in healthy elderly individuals. , 2015, International journal of clinical and experimental medicine.
[54] H. Sul,et al. Transcriptional regulation of hepatic lipogenesis , 2015, Nature Reviews Molecular Cell Biology.
[55] Enric Llorens-Bobadilla,et al. Single-Cell Transcriptomics Reveals a Population of Dormant Neural Stem Cells that Become Activated upon Brain Injury. , 2015, Cell stem cell.
[56] B. Göttgens. Regulatory network control of blood stem cells. , 2015, Blood.
[57] C. Eaves. Hematopoietic stem cells: concepts, definitions, and the new reality. , 2015, Blood.
[58] T. Suda,et al. The analysis, roles and regulation of quiescence in hematopoietic stem cells , 2014, Development.
[59] E. Mylonakis,et al. Graft-Versus-Host Disease Prophylaxis after Transplantation: A Network Meta-Analysis , 2014, PloS one.
[60] K. Sauer,et al. IP3 3-kinase B controls hematopoietic stem cell homeostasis and prevents lethal hematopoietic failure in mice. , 2014, Blood.
[61] K. Kaufmann,et al. Reactive oxygen species regulate hematopoietic stem cell self-renewal, migration and development, as well as their bone marrow microenvironment. , 2014, Antioxidants & redox signaling.
[62] S. Morrison,et al. Cellular Differences in Protein Synthesis Regulate Tissue Homeostasis , 2014, Cell.
[63] J. Cavaille,et al. The miR‐379/miR‐410 cluster at the imprinted Dlk1‐Dio3 domain controls neonatal metabolic adaptation , 2014, The EMBO journal.
[64] A. Hirao,et al. Pleiotropic roles of mTOR complexes in haemato-lymphopoiesis and leukemogenesis. , 2014, Journal of biochemistry.
[65] Jeffrey A. Magee,et al. Haematopoietic stem cells require a highly regulated protein synthesis rate , 2014, Nature.
[66] S. Gerson,et al. Bcl2 overexpression rescues the hematopoietic stem cell defects in Ku70-deficient mice by restoration of quiescence. , 2014, Blood.
[67] Jian-Bing Fan,et al. Reduced lymphoid lineage priming promotes human hematopoietic stem cell expansion. , 2014, Cell stem cell.
[68] Yi Zheng,et al. Mouse gene targeting reveals an essential role of mTOR in hematopoietic stem cell engraftment and hematopoiesis , 2013, Haematologica.
[69] A. Pause,et al. Birt–Hogg–Dubé: tumour suppressor function and signalling dynamics central to folliculin , 2013, Familial Cancer.
[70] L. Schmidt. Birt–Hogg–Dubé syndrome: from gene discovery to molecularly targeted therapies , 2013, Familial Cancer.
[71] M. Stojkovic,et al. A Novel Human Glycoprotein ACA is an Upstream Regulator of Human Hematopoiesis , 2013, Bulletin of Experimental Biology and Medicine.
[72] L. Platanias,et al. The evolution of the TOR pathway and its role in cancer , 2013, Oncogene.
[73] K. Elkon,et al. Cutting Edge: Type I IFN Drives Emergency Myelopoiesis and Peripheral Myeloid Expansion during Chronic TLR7 Signaling , 2013, The Journal of Immunology.
[74] S. Armstrong,et al. mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis. , 2012, Cell stem cell.
[75] Jeffrey A. Magee,et al. Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression. , 2012, Cell stem cell.
[76] P. Pandolfi,et al. A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance , 2012, Nature Medicine.
[77] D. Alessi,et al. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. , 2012, Gastroenterology.
[78] M. Hall,et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. , 2012, Cell metabolism.
[79] A. Ferguson-Smith,et al. Imprinted Gene Dosage Is Critical for the Transition to Independent Life , 2012, Cell metabolism.
[80] T. Suda,et al. Regulation of reactive oxygen species in stem cells and cancer stem cells , 2012, Journal of cellular physiology.
[81] M. Buitenhuis,et al. The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia. , 2012, Blood.
[82] E. Pietras,et al. Cell cycle regulation in hematopoietic stem cells , 2011, The Journal of cell biology.
[83] Akinobu Matsumoto,et al. p57 is required for quiescence and maintenance of adult hematopoietic stem cells. , 2011, Cell stem cell.
[84] K. Nakayama,et al. Ex vivo maintenance of hematopoietic stem cells by quiescence induction through Fbxw7α overexpression. , 2011, Blood.
[85] Jun Seita,et al. Hematopoietic stem cell: self‐renewal versus differentiation , 2010, Wiley interdisciplinary reviews. Systems biology and medicine.
[86] M. Birnbaum,et al. AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species. , 2010, Blood.
[87] D. Gilliland,et al. Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice. , 2010, Blood.
[88] W. Tong,et al. Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice. , 2009, The Journal of clinical investigation.
[89] E. Laurenti,et al. Balancing dormant and self-renewing hematopoietic stem cells. , 2009, Current opinion in genetics & development.
[90] D. Allman. Faculty Opinions recommendation of Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. , 2009 .
[91] P. Lio’,et al. Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair , 2008, Cell.
[92] David A. Williams,et al. mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization , 2008, Proceedings of the National Academy of Sciences.
[93] Yang Liu,et al. TSC–mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species , 2008, The Journal of experimental medicine.
[94] Il-Jin Kim,et al. FBXW7 Targets mTOR for Degradation and Cooperates with PTEN in Tumor Suppression , 2008, Science.
[95] Yasuo Ikeda,et al. PML targeting eradicates quiescent leukaemia-initiating cells , 2008, Nature.
[96] I. Weissman,et al. Stems Cells and the Pathways to Aging and Cancer , 2008, Cell.
[97] Xi C. He,et al. N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells. , 2007, Cell stem cell.
[98] P. Kulkarni,et al. Anemia , 2007 .
[99] David G Kent,et al. Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect. , 2006, The Journal of clinical investigation.
[100] S. Morrison,et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells , 2006, Nature.
[101] Xi C. He,et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention , 2006, Nature.
[102] M. Hall,et al. TOR Signaling in Growth and Metabolism , 2006, Cell.
[103] B. Edgar,et al. Rheb promotes cell growth as a component of the insulin/TOR signalling network , 2003, Nature Cell Biology.
[104] P. Terness,et al. A Novel Human Erythrocyte Glycosylphosphatidylinositol (GPI)-anchored Glycoprotein ACA , 2002, The Journal of Biological Chemistry.
[105] Tian Xu,et al. Akt regulates growth by directly phosphorylating Tsc2 , 2002, Nature Cell Biology.
[106] K. Inoki,et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.
[107] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[108] I. Weissman,et al. Stem Cells Units of Development, Units of Regeneration, and Units in Evolution , 2000, Cell.
[109] I. Weissman,et al. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[110] S Povey,et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. , 1997, Science.
[111] B. Williams,et al. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. , 1997, Experimental hematology.
[112] I. Weissman,et al. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. , 1994, Immunity.
[113] S. Thomas,et al. Identification and characterization of the tuberous sclerosis gene on chromosome 16 , 1993, Cell.
[114] M. Ogawa,et al. Differentiation and proliferation of hematopoietic stem cells. , 1993, Blood.
[115] E. Pietras,et al. PI 3 K alpha and delta promote hematopoietic stem cell activation , 2019 .
[116] S. Lachance,et al. Defining the role of sirolimus in the management of graft-versus-host disease: from prophylaxis to treatment. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[117] F. Rahim,et al. Adverse Effect of High Glucose Concentration on Stem Cell Therapy , 2013, International journal of hematology-oncology and stem cell research.
[118] Lei Wang,et al. Significance of mTOR Signaling and Its Inhibitor Against Cancer Stem-Like Cells in Colorectal Cancer , 2013, Annals of Surgical Oncology.
[119] Rudolf Jaenisch,et al. Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells , 2009, Nature Biotechnology.
[120] Leo Koenderman,et al. Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis. , 2008, Blood.